EDGAR Filing Documents for 0000909661-08-000007

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

SEC Accession No. 0000909661-08-000007

Filing Date

2008-01-08

Accepted

2008-01-08 17:22:36

Documents

Group Members

ANDREW J.M. SPOKESASHISH H. PANTCHUN R. DINGDAVID I. COHENDEREK C. SCHRIERDOUGLAS M. MACMAHONFARALLON CAPITAL INSTITUTIONAL PARTNERS II, L.P.FARALLON CAPITAL INSTITUTIONAL PARTNERS III, L.P.FARALLON CAPITAL INSTITUTIONAL PARTNERS, L.P.FARALLON CAPITAL OFF

Document Format Files

Seq	Description	Document	Type	Size
1	13GA1 FOR CHARLES RIVER INTERNATIONAL, INC.	charlesrvrintntl13ga1.htm	SC 13G/A	736920
	Complete submission text file	0000909661-08-000007.txt		740074

Mailing Address ONE MARITIME PLAZA SUITE 2100 SAN FRANCISCO CA 94111

Business Address ONE MARITIME PLAZA SUITE 2100 SAN FRANCISCO CA 94111 (415)421-2132

FARALLON CAPITAL MANAGEMENT LLC (Filed by) CIK: 0000909661 (see all company filings)

IRS No.: 943240279
Type: SC 13G/A

Mailing Address 251 BALLARDVALE ST WILMINGTON MA 01887

Business Address 261 BALLARDVALE STREET WILMINGTON MA 01867 9786586000

CHARLES RIVER LABORATORIES INTERNATIONAL INC (Subject) CIK: 0001100682 (see all company filings)

IRS No.: 061397316
Type: SC 13G/A | Act: 34 | File No.: 005-59553 | Film No.: 08518513
SIC: 2836 Biological Products, (No Diagnostic Substances)